Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma

British Journal of Haematology

Volumn 151, Issue 2, 2010, Pages 195-197

  Storto, Giovanni ^a   Di Giorgio, Eugenio ^b   De Renzo, Amalia ^c   Pizzuti, Laura Micol ^d   Cerciello, Giuseppe ^c   Nardelli, Anna ^b   Capacchione, Daniela ^a   Castaldi, Elena ^b   Ortosecco, Giovanni ^b   Pace, Leonardo ^c,d  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

FDG; metabolic activity; positron emission tomography; standard uptake value; T cell lymphomas

Indexed keywords

FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN;

ADULT; AGED; B CELL LYMPHOMA; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; TUMOR VOLUME;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77957366386     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08335.x     Document Type: Letter

References (10)

1. Aloj, L., Caraco, C., Jagoda, E., Eckelman, W.C. Neumann, R.D. (1999) Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Research, 59, 4709 4714.
2. Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F. Meignan, M. (2005) [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood, 106, 1376 1381.
3. Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.F., Rigo, P. Fillet, G. (2001) Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12, 825 830.
4. Kuo, P.H., McClennan, B.L., Carlson, K., Wilson, L.D., Edelson, R.L., Heald, P.W. Girardi, M. (2008) FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Molecular Imaging and Biology, 10, 74 81.
5. Leskinen-Kallio, S., Ruotsalainen, U., Någren, K., Teräs, M. Joensuu, H. (1991) Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. Journal of Nuclear Medicine, 32, 1211 1218.
6. Mikhaeel, N.G., Hutchings, M., Fields, P.A., O'Doherty, M.J. Timothy, A.R. (2005) FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Annals of Oncology, 16, 1514 1523.
7. Pangalis, G.A. Tsavaris, N.B. (1986) Glucose-6-phosphatase activity of Reed-Sternberg and Hodgkin cells. Hematological Oncology, 4, 261 266.
8. Schoder, H., Noy, A., Gonen, M., Weng, L., Green, D., Erdi, Y.E., Larson, S.M. Yeung, H.W. (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 23, 4643 4651.
9. Tang, B., Douglas-Nikitin, V., Balon, H., Wong, C.O., Khong, P.L. Wong, C.Y. (2009) Exceptionally low metabolic activity in aggressive peripheral T-cell lymphoma. Nuclear Medicine Communications, 30, 838 840.
10. Whitcomb, C.C., Olivella, J.E. Byrne, Jr., G.E. (1983) T-cell lymphoma-leukemia. Pathologic observations in three cases. Cancer, 52, 1202 1209.